Newly diagnosed diabetes in patients with mild to moderate COVID-19

BACKGROUND AND AIMS: We aimed to study newly diagnosed diabetes in patients with mild to moderate COVID-19. METHODS: This was a retrospective cohort study of COVID-19 patients who were admitted to a tertiary care hospital in India from May to October 2020. RESULTS: Of 102 patients, 21 (20.6%) had ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathish, Thirunavukkarasu, Chandrika Anton, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925231/
https://www.ncbi.nlm.nih.gov/pubmed/33706188
http://dx.doi.org/10.1016/j.dsx.2021.02.034
Descripción
Sumario:BACKGROUND AND AIMS: We aimed to study newly diagnosed diabetes in patients with mild to moderate COVID-19. METHODS: This was a retrospective cohort study of COVID-19 patients who were admitted to a tertiary care hospital in India from May to October 2020. RESULTS: Of 102 patients, 21 (20.6%) had newly diagnosed diabetes on admission. Of which, four (19.0%) had marked hyperglycemia with no ketosis or ketoacidosis. CONCLUSION: In this study of patients with mild to moderate COVID-19, newly diagnosed diabetes and marked hyperglycemia in those with newly diagnosed diabetes were common.

Ejemplares similares